Company Filing History:
Years Active: 2015
Title: Zhaoyong Li: Innovator in Colorectal Cancer Diagnostics
Introduction
Zhaoyong Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical diagnostics, particularly in colorectal cancer. His innovative work focuses on the development of molecular markers that can aid in the early detection and treatment of this prevalent disease.
Latest Patents
Zhaoyong Li holds a patent for "Compositions and methods for micro-RNA expression profiling of colorectal cancer." This invention relates to compositions and methods for microRNA (miRNA) expression profiling of colorectal cancer. The patent describes a diagnostic kit that includes a plurality of nucleic acid molecules, each encoding a miRNA sequence. These molecules are differentially expressed in target cells compared to control cells, providing a nucleic acid expression signature indicative of colorectal cancer presence or predisposition. The invention also encompasses methods for identifying target cells and a pharmaceutical composition for the prevention and treatment of colorectal cancer.
Career Highlights
Zhaoyong Li is affiliated with Fudan University, where he continues to advance research in cancer diagnostics. His work has garnered attention for its potential to improve early detection and treatment strategies for colorectal cancer. With a focus on innovative solutions, he has established himself as a key figure in the field.
Collaborations
Zhaoyong Li has collaborated with notable colleagues, including Ying Wu and Hongguang Zhu. These partnerships have contributed to the development of his groundbreaking research and patents.
Conclusion
Zhaoyong Li's contributions to colorectal cancer diagnostics through his innovative patent highlight the importance of research in improving healthcare outcomes. His work exemplifies the potential of molecular markers in the early detection and treatment of cancer.